Year Joined

  • 2008

Areas of Expertise

  • Technology 



Ming Hsieh President and FounderFulgent Therapeutics


Chairman and CEO

Fulgent Therapeutics

Mr. Hsieh is the President and Founder of Fulgent Therapeutics Inc., a cancer drug research and development company. From October 2010 to June 2012, Mr. Hsieh served as the President of 3M Cogent, Inc., a provider of global biometric identification solutions, following the acquisition of Cogent, Inc. by 3M Company in 2010. Prior to the acquisition, Mr. Hsieh served as the Chief Executive Officer, President and Chairman of the Board of Directors of Cogent since founding Cogent in 1990. Prior to that, Mr. Hsieh was a research and development engineer at International Rectifier Corporation, a manufacturer of semiconductors, from 1985 to 1987. Mr. Hsieh received a B.S.E.E. from the University of Southern California and an M.S.E.E. from University of Southern California.


  • Committee of 100

    Extraordinary Chinese Americans

  • Ensuring Full Inclusion in America
    Advancing U.S.-China Relations
  • Connect
  • Contact
  • 257 Park Avenue South
    19th Fl.
    New York, NY 10010 Phone: 212-371-6565
    Fax: 212-371-9009

  • Sign Up For Updates